Bronchioloalveolar Carcinoma

Also known as: Bronchioloalveolar Cancer / Bronchoalveolar Cell Lung Cancer / Bronchioloalveolar Lung Carcinoma / Bronchiolo-alveolar adenocarcinoma (morphologic abnormality) / Alveolar adenocarcinoma (morphologic abnormality) / Adenocarcinoma, Bronchiolo-Alveolar / Bronchioalveolar carcinoma / Alveolar cell carcinoma

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00112Bevacizumab1Terminated1
DB00958Carboplatin1Terminated2
DB00515Cisplatin1Completed1
DB00515Cisplatin1Terminated1
DB01248Docetaxel1Terminated1
DB00530Erlotinib1Terminated1
DB00773Etoposide1Completed1
DB00773Etoposide1Terminated1
DB01229Paclitaxel1Terminated2
DB00642Pemetrexed1Completed1
DB00112Bevacizumab2Completed1
DB00112Bevacizumab2Terminated1
DB00188Bortezomib2Completed1
DB00958Carboplatin2Active Not Recruiting1
DB00958Carboplatin2Completed1
DB00958Carboplatin2Terminated1
DB00002Cetuximab2Completed1
DB00515Cisplatin2Completed1
DB05759Cixutumumab2Terminated1
DB12250Cixutumumab2Terminated1
DB01248Docetaxel2Completed1
DB00530Erlotinib2Completed3
DB00099Filgrastim2Completed1
DB00317Gefitinib2Completed3
DB00331Metformin2Active Not Recruiting1
DB01229Paclitaxel2Active Not Recruiting1
DB01229Paclitaxel2Completed2
DB01229Paclitaxel2Terminated1
DB00019Pegfilgrastim2Completed1
DB00642Pemetrexed2Completed1
DB00112Bevacizumab2 / 3Completed1
DB00958Carboplatin2 / 3Completed1
DB01229Paclitaxel2 / 3Completed1
DB00958Carboplatin3Completed1
DB00515Cisplatin3Completed1
DB01248Docetaxel3Completed1
DB00773Etoposide3Completed1
DB00317Gefitinib3Completed2
DB01229Paclitaxel3Completed1